Email this article IMMUNOGENIC CANCER-TESTIS ANTIGENS AND THEIR GENES IN MALIGNANT TUMORS
- Authors: Golyshko P.V.1,2, Baryshnikov K.A.1, Baryshnikov' A.Y.1
-
Affiliations:
- ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»
- ГКБ № 57
- Issue: Vol 14, No 2 (2015)
- Pages: 31-38
- Section: REVIEWS
- Published: 30.06.2015
- URL: https://bioterapevt.abvpress.ru/jour/article/view/15
- DOI: https://doi.org/10.17650/1726-9784-2015-14-2-31-38
- ID: 15
Cite item
Open Access
Access granted
Subscription or Fee Access
Abstract
The analysis of CTG and CTA expression in malignant tumors described in this review has been showed that different types of tumors are significantly different from each other according to the frequency of CTA mRNA expression. Melanoma, ovarian cancer and lung cancer have a very high frequency of CTA expression. Lymphoma, kidney cancer, pancreatic cancer have a low frequency of CTA expression. Breast cancer, bladder cancer, prostate cancer demonstrate an intermediate level of CTA expression. High degree malignant tumors in late clinical stage with metastases showed a greater incidence of CTA -gene expression. CTA-genes are expressed together in tumor. If the tumor is positive for one CTA-gene then the expression of several genes is possible. Immunogenic CTA-s are a well object for anti-tumor vaccines creating.
About the authors
P. V. Golyshko
ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»; ГКБ № 57
Author for correspondence.
Email: golp@tut.by
Russian Federation
K. A. Baryshnikov
ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»Russian Federation
A. Yu. Baryshnikov'
ФГБНУ «Российский онкологический научный центр им. Н.Н. Блохина»Russian Federation
References
Supplementary files
